Get started
Author

Kanokon Suwannasin

Observed names: K Suwannasin, Suwannasin Kanokon, Suwannasin, Kanokon
OpenAlex ID: A5018485386
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
2017 · Mallika Imwong, Kanokon Suwannasin, et al. · The Lancet Infectious Diseases · 485
PDF
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
2020 · Mallika Imwong, Mehul Dhorda, et al. · The Lancet Infectious Diseases · 169
Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi
2018 · Mallika Imwong, Wanassanan Madmanee, et al. · The Journal of Infectious Diseases · 166
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
2023 · William H K Schilling, Podjanee Jittamala, et al. · The Lancet Infectious Diseases · 94
PDF
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
2021 · Ghulam R. Awab, Fahima Aaram, et al. · eLife · 47
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
2023 · William HK Schilling, Podjanee Jittamala, et al. · eLife · 22
PDF
Utility of Plasmodium falciparum DNA from rapid diagnostic test kits for molecular analysis and whole genome amplification
2020 · Suttipat Srisutham, Kanokon Suwannasin, et al. · Malaria Journal · 17
PDF
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
2020 · Rungniran Sugaram, Kanokon Suwannasin, et al. · Malaria Journal · 16
PDF
Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
2021 · Suttipat Srisutham, Kanokon Suwannasin, et al. · Malaria Journal · 15
PDF
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
2025 · Podjanee Jittamala, Simon Boyd, et al. · EClinicalMedicine · 13
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
2023 · Mavuto Mukaka, Marie A. Onyamboko, et al. · EBioMedicine · 12
PDF
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
2025 · William H K Schilling, Podjanee Jittamala, et al. · The Lancet Infectious Diseases · 8
In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand
2023 · Suwanna Chaorattanakawee, Varakorn Kosaisavee, et al. · Malaria Journal · 4
PDF
Pharmacometric Evaluation of Sulfadoxine-Pyrimethamine-Amodiaquine and Dihydroartemisinin-Piperaquine Seasonal Malaria Chemoprevention in Northern Uganda
2025 · Craig Bonnington, Anthony Nuwa, et al. · Clinical Infectious Diseases · 3
PDF
Changing genetic profiles of Plasmodium falciparum piperaquine resistance in Southeast Asia over 25 years
2026 · Suttipat Srisutham, Kanokon Suwannasin, et al. · Antimicrobial Agents and Chemotherapy · 2
Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination
2025 · Thidathip Wongsurawat, Piroon Jenjaroenpun, et al. · Scientific Reports · 2
PDF
Parasitological efficacy of sulfadoxine-pyrimethamine and amodiaquine for seasonal malaria chemoprevention in Africa
2026 · Chayanin Sararat, Paul Sondo, et al. · Nature Communications
PDF
Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial
2026 · Podjanee Jittamala, William H K Schilling, et al. · The Lancet Infectious Diseases
Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda
2025 · C. Bonnington, A. Nuwa, et al. · medRxiv
PDF
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19
2025 · William HK Schilling, Podjanee Jittamala, et al. · medRxiv
PDF
Author response: Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
2023 · William HK Schilling, Podjanee Jittamala, et al.
Additional file 2 of In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand
2023 · Chaorattanakawee, Suwanna, Kosaisavee, Varakorn, et al. · Figshare
Additional file 1 of In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand
2023 · Chaorattanakawee, Suwanna, Kosaisavee, Varakorn, et al. · Figshare
Additional file 3 of Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
2021 · Suttipat Srisutham, Kanokon Suwannasin, et al. · Figshare
Additional file 4 of Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
2021 · Suttipat Srisutham, Kanokon Suwannasin, et al. · Figshare
Works count: 37
Citation count: 1,075
H-index: 11
I10-index: 11
Year
Topic
Type